<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33846297</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>12</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-4889</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Apr</Month><Day>12</Day></PubDate></JournalIssue><Title>Cell death &amp; disease</Title><ISOAbbreviation>Cell Death Dis</ISOAbbreviation></Journal><ArticleTitle>Simvastatin accelerated motoneurons death in SOD1<sup>G93A</sup> mice through inhibiting Rab7-mediated maturation of late autophagic vacuoles.</ArticleTitle><Pagination><StartPage>392</StartPage><MedlinePgn>392</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">392</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41419-021-03669-w</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease caused by motoneuron loss, for which there is currently no effective treatment. Statins, as inhibitors of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase, are used as drugs for treatment for a variety of disease such as ischemic diseases, neurodegenerative diseases, cancer, and inflammation. However, our previous evidence has demonstrated that simvastatin leads to cytotoxicity in NSC34-hSOD1<sup>G93A</sup> cells by aggravating the impairment of autophagic flux, but the role of simvastatin in ALS model remains elusive. In present study, we reported that after simvastatin treatment, SOD1<sup>G93A</sup> mice showed early onset of the disease phenotype and shortened life span, with aggravated autophagic flux impairment and increased aggregation of SOD1 protein in spinal cord motoneurons (MNs) of SOD1<sup>G93A</sup> mice. In addition, simvastatin repressed the ability of Rab7 localization on the membrane by inhibiting isoprenoid synthesis, leading to impaired late stage of autophagic flux rather than initiation. This study suggested that simvastatin significantly worsened impairment of late autophagic flux, resulting in massive MNs death in spinal cord and accelerated disease progression of SOD1<sup>G93A</sup> mice. Together, these findings might imply a potential risk of clinic application of statins in ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurological Laboratory of Hebei Province, Shijiazhuang, Hebei, 050000, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yafei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurological Laboratory of Hebei Province, Shijiazhuang, Hebei, 050000, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huo</LastName><ForeName>Jia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurological Laboratory of Hebei Province, Shijiazhuang, Hebei, 050000, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Shuai</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurological Laboratory of Hebei Province, Shijiazhuang, Hebei, 050000, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wen</LastName><ForeName>Ya</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurological Laboratory of Hebei Province, Shijiazhuang, Hebei, 050000, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurological Laboratory of Hebei Province, Shijiazhuang, Hebei, 050000, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurological Laboratory of Hebei Province, Shijiazhuang, Hebei, 050000, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yaling</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-6221-6021</Identifier><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, P.R. China. lyldoctor@163.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurological Laboratory of Hebei Province, Shijiazhuang, Hebei, 050000, P.R. China. lyldoctor@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Rui</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, P.R. China. ruilidr@126.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurological Laboratory of Hebei Province, Shijiazhuang, Hebei, 050000, P.R. China. ruilidr@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cell Death Dis</MedlineTA><NlmUniqueID>101524092</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000090802">rab7 GTP-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000716463">rab7 GTP-binding proteins, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000716465">rab7 GTP-binding proteins, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>AGG2FN16EV</RegistryNumber><NameOfSubstance UI="D019821">Simvastatin</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.5.2</RegistryNumber><NameOfSubstance UI="D020691">rab GTP-Binding Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019821" MajorTopicYN="N">Simvastatin</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014617" MajorTopicYN="N">Vacuoles</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020691" MajorTopicYN="N">rab GTP-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000090802" MajorTopicYN="N">rab7 GTP-Binding Proteins</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>13</Day><Hour>5</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33846297</ArticleId><ArticleId IdType="pmc">PMC8041862</ArticleId><ArticleId IdType="doi">10.1038/s41419-021-03669-w</ArticleId><ArticleId IdType="pii">10.1038/s41419-021-03669-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, et al. Genetic screening in sporadic ALS and FTD. J. Neurol. Neurosurg. Psychiatry. 2017;88:1042&#x2013;1044. doi: 10.1136/jnnp-2017-315995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-315995</ArticleId><ArticleId IdType="pmc">PMC5740553</ArticleId><ArticleId IdType="pubmed">28642287</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen D, Thombre R, Wang J. Autophagy as a common pathway in amyotrophic lateral sclerosis. Neurosci. Lett. 2019;697:34&#x2013;48. doi: 10.1016/j.neulet.2018.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2018.04.006</ArticleId><ArticleId IdType="pmc">PMC6170747</ArticleId><ArticleId IdType="pubmed">29626651</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L, Kirby J, Grierson AJ, Sendtner M, Shaw PJ. Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat. Rev. Neurol. 2011;7:616&#x2013;630. doi: 10.1038/nrneurol.2011.152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.152</ArticleId><ArticleId IdType="pubmed">22051914</ArticleId></ArticleIdList></Reference><Reference><Citation>Butti Z, Patten SA. RNA dysregulation in amyotrophic lateral sclerosis. Front. Genet. 2018;9:712. doi: 10.3389/fgene.2018.00712.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2018.00712</ArticleId><ArticleId IdType="pmc">PMC6349704</ArticleId><ArticleId IdType="pubmed">30723494</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, et al. Selective autophagy of intracellular organelles: recent research advances. Theranostics. 2021;11:222&#x2013;256. doi: 10.7150/thno.49860.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.49860</ArticleId><ArticleId IdType="pmc">PMC7681076</ArticleId><ArticleId IdType="pubmed">33391472</ArticleId></ArticleIdList></Reference><Reference><Citation>Dikic I, Elazar Z. Mechanism and medical implications of mammalian autophagy. Nat. Rev. Mol. Cell Biol. 2018;19:349&#x2013;364. doi: 10.1038/s41580-018-0003-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-018-0003-4</ArticleId><ArticleId IdType="pubmed">29618831</ArticleId></ArticleIdList></Reference><Reference><Citation>Stamatakou E, et al. Mendelian neurodegenerative disease genes involved in autophagy. Cell Disco. 2020;6:24. doi: 10.1038/s41421-020-0158-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-020-0158-y</ArticleId><ArticleId IdType="pmc">PMC7198619</ArticleId><ArticleId IdType="pubmed">32377374</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerra F, Bucci C. Multiple roles of the small GTPase Rab7. Cells. 2016;5:34&#x2013;62. doi: 10.3390/cells5030034.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells5030034</ArticleId><ArticleId IdType="pmc">PMC5040976</ArticleId><ArticleId IdType="pubmed">27548222</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroupe C. This is the end: regulation of Rab7 nucleotide binding in endolysosomal trafficking and autophagy. Front. Cell Dev. Biol. 2018;6:129. doi: 10.3389/fcell.2018.00129.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2018.00129</ArticleId><ArticleId IdType="pmc">PMC6176412</ArticleId><ArticleId IdType="pubmed">30333976</ArticleId></ArticleIdList></Reference><Reference><Citation>Fassio A, et al. Emerging role of the autophagy/lysosomal degradative pathway in neurodevelopmental disorders with epilepsy. Front. Cell Neurosci. 2020;14:39. doi: 10.3389/fncel.2020.00039.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.00039</ArticleId><ArticleId IdType="pmc">PMC7082311</ArticleId><ArticleId IdType="pubmed">32231521</ArticleId></ArticleIdList></Reference><Reference><Citation>Gioved&#xec; S, Ravanelli MM, Parisi B, Bettegazzi B, Guarnieri FC. Dysfunctional autophagy and endolysosomal system in neurodegenerative diseases: relevance and therapeutic options. Front. Cell Neurosci. 2020;14:602116. doi: 10.3389/fncel.2020.602116.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.602116</ArticleId><ArticleId IdType="pmc">PMC7773602</ArticleId><ArticleId IdType="pubmed">33390907</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuang H, et al. Exploring the bi&#x2010;directional relationship between autophagy and Alzheimer&#x2019;s. CNS Neurosci. Ther. 2020;26:155&#x2013;166. doi: 10.1111/cns.13216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.13216</ArticleId><ArticleId IdType="pmc">PMC6978262</ArticleId><ArticleId IdType="pubmed">31503421</ArticleId></ArticleIdList></Reference><Reference><Citation>Cipolat Mis MS, Brajkovic S, Frattini E, Di FA, Corti S. Autophagy in motor neuron disease: key pathogenetic mechanisms and therapeutic targets. Mol. Cell. Neurosci. 2016;72:84&#x2013;90. doi: 10.1016/j.mcn.2016.01.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2016.01.012</ArticleId><ArticleId IdType="pubmed">26837042</ArticleId></ArticleIdList></Reference><Reference><Citation>Wennerberg K, Rossman KL, Der CJ. The Ras superfamily at a glance. J. Cell. Sci. 2005;118:843&#x2013;846. doi: 10.1242/jcs.01660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.01660</ArticleId><ArticleId IdType="pubmed">15731001</ArticleId></ArticleIdList></Reference><Reference><Citation>Miettinen TP, Bj&#xf6;rklund M. Mevalonate pathway regulates cell size homeostasis and proteostasis through autophagy. Cell Rep. 2015;13:2610&#x2013;2620. doi: 10.1016/j.celrep.2015.11.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2015.11.045</ArticleId><ArticleId IdType="pmc">PMC4709259</ArticleId><ArticleId IdType="pubmed">26686643</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruenbacher G, Thurnher M. Mevalonate metabolism in cancer stemness and trained immunity. Front. Oncol. 2018;8:394. doi: 10.3389/fonc.2018.00394.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2018.00394</ArticleId><ArticleId IdType="pmc">PMC6160868</ArticleId><ArticleId IdType="pubmed">30298120</ArticleId></ArticleIdList></Reference><Reference><Citation>Tricarico PM, Crovella S, Celsi F. Mevalonate pathway blockade, mitochondrial dysfunction and autophagy: a possible link. Int J. Mol. Sci. 2015;16:16067&#x2013;16084. doi: 10.3390/ijms160716067.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms160716067</ArticleId><ArticleId IdType="pmc">PMC4519939</ArticleId><ArticleId IdType="pubmed">26184189</ArticleId></ArticleIdList></Reference><Reference><Citation>Tricarico PM, Romeo A, Gratton R, Crovella S, Celsi F. Lack of prenylated proteins, autophagy impairment and apoptosis in SH-SY5Y neuronal cell model of mevalonate kinase deficiency. Cell. Physiol. Biochem. 2017;41:1649&#x2013;1660. doi: 10.1159/000471235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000471235</ArticleId><ArticleId IdType="pubmed">28359055</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazi DS, Penko JM, Bibbins-Domingo K. Statins for primary prevention of cardiovascular disease: review of evidence and recommendations for clinical practice. Med. Clin. North Am. 2017;101:689&#x2013;699. doi: 10.1016/j.mcna.2017.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcna.2017.03.001</ArticleId><ArticleId IdType="pubmed">28577620</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z, et al. Association of blood lipids, atherosclerosis and statin use with dementia and cognitive impairment after stroke: a systematic review and meta-analysis. Ageing Res. Rev. 2020;57:100962. doi: 10.1016/j.arr.2019.100962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2019.100962</ArticleId><ArticleId IdType="pubmed">31505259</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung JW, et al. Intensive statin treatment in acute ischaemic stroke patients with intracranial atherosclerosis: a high-resolution magnetic resonance imaging study (STAMINA-MRI Study) J. Neurol. Neurosurg. Psychiatry. 2020;91:204&#x2013;211. doi: 10.1136/jnnp-2019-320893.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2019-320893</ArticleId><ArticleId IdType="pubmed">31371644</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Dong J, Yu Z. Pleiotropic use of statins as non-lipid-lowering drugs. Int. J. Biol. Sci. 2020;16:2704&#x2013;2711. doi: 10.7150/ijbs.42965.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.42965</ArticleId><ArticleId IdType="pmc">PMC7586431</ArticleId><ArticleId IdType="pubmed">33110390</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan D, et al. Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial. Lancet Neurol. 2017;16:591&#x2013;600. doi: 10.1016/S1474-4422(17)30113-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30113-8</ArticleId><ArticleId IdType="pmc">PMC5507768</ArticleId><ArticleId IdType="pubmed">28600189</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeedi Saravi SS, Saeedi Saravi SS, Arefidoust A, Dehpour AR. The beneficial effects of HMG-CoA reductase inhibitors in the processes of neurodegeneration. Metab. Brain Dis. 2017;32:949&#x2013;965. doi: 10.1007/s11011-017-0021-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11011-017-0021-5</ArticleId><ArticleId IdType="pubmed">28578514</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulchandani R, Lyngdoh T, Kakkar AK. Statin use and safety concerns: an overview of the past, present and the future. Expert Opin. Drug Saf. 2020;19:1011&#x2013;1024. doi: 10.1080/14740338.2020.1796966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14740338.2020.1796966</ArticleId><ArticleId IdType="pubmed">32668998</ArticleId></ArticleIdList></Reference><Reference><Citation>Meurer L, Cohen SM. Drug-induced liver injury from statins. Clin. Liver Dis. 2020;24:107&#x2013;119. doi: 10.1016/j.cld.2019.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cld.2019.09.007</ArticleId><ArticleId IdType="pubmed">31753243</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YF, et al. Simvastatin enhances muscle regeneration through autophagic defect-mediated inflammation and mTOR activation in G93ASOD1 mice. Mol. Neurobiol. 2021;58:1593&#x2013;1606. doi: 10.1007/s12035-020-02216-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-020-02216-6</ArticleId><ArticleId IdType="pubmed">33222146</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi WJ, et al. Simvastatin aggravates impaired autophagic flux in NSC34-hSOD1G93A cells through inhibition of geranylgeranyl pyrophosphate synthesis. Neuroscience. 2019;409:130&#x2013;141. doi: 10.1016/j.neuroscience.2019.04.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2019.04.034</ArticleId><ArticleId IdType="pubmed">31051215</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Weydt P, Hongso Y, Kliot M, Moller T. Assessing disease onset and progression in the SOD1 mouse model of ALS. Neuroreport. 2003;14:1051&#x2013;1054.</Citation><ArticleIdList><ArticleId IdType="pubmed">12802201</ArticleId></ArticleIdList></Reference><Reference><Citation>Vercelli A, et al. Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 2008;31:395&#x2013;405. doi: 10.1016/j.nbd.2008.05.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2008.05.016</ArticleId><ArticleId IdType="pubmed">18586098</ArticleId></ArticleIdList></Reference><Reference><Citation>Klionsky DJ, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) Autophagy. 2016;12:1&#x2013;222. doi: 10.1080/15548627.2015.1100356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2015.1100356</ArticleId><ArticleId IdType="pmc">PMC4835977</ArticleId><ArticleId IdType="pubmed">26799652</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucocq JM, Hacker C. Cutting a fine figure: on the use of thin sections in electron microscopy to quantify autophagy. Autophagy. 2013;9:1443&#x2013;1448. doi: 10.4161/auto.25570.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.25570</ArticleId><ArticleId IdType="pubmed">23881027</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan L, et al. Autophagosome maturation mediated by Rab7 contributes to neuroprotection of hypoxic preconditioning against global cerebral ischemia in rats. Cell Death Dis. 2017;8:e2949. doi: 10.1038/cddis.2017.330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2017.330</ArticleId><ArticleId IdType="pmc">PMC5550874</ArticleId><ArticleId IdType="pubmed">28726776</ArticleId></ArticleIdList></Reference><Reference><Citation>Cashman NR, et al. Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev. Dyn. 1992;194:209&#x2013;221. doi: 10.1002/aja.1001940306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/aja.1001940306</ArticleId><ArticleId IdType="pubmed">1467557</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, et al. A new cellular model of pathological TDP-43: the neurotoxicity of stably expressed CTF25 of TDP-43 depends on the proteasome. Neuroscience. 2014;281:88&#x2013;98. doi: 10.1016/j.neuroscience.2014.09.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2014.09.043</ArticleId><ArticleId IdType="pubmed">25270903</ArticleId></ArticleIdList></Reference><Reference><Citation>Salehi M, Nikkhah M, Ghasemi A, Arab SS. Mitochondrial membrane disruption by aggregation products of ALS-causing superoxide dismutase-1 mutants. Int. J. Biol. Macromol. 2015;75:290&#x2013;297. doi: 10.1016/j.ijbiomac.2015.01.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2015.01.022</ArticleId><ArticleId IdType="pubmed">25600987</ArticleId></ArticleIdList></Reference><Reference><Citation>Par&#xe9; B, et al. Misfolded SOD1 pathology in sporadic amyotrophic lateral sclerosis. Sci. Rep. 2018;8:14223&#x2013;14237. doi: 10.1038/s41598-018-31773-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-31773-z</ArticleId><ArticleId IdType="pmc">PMC6155098</ArticleId><ArticleId IdType="pubmed">30242181</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, et al. Copper-binding-site-null SOD1 causes ALS in transgenic mice: aggregates of non-native SOD1 delineate a common feature. Hum. Mol. Genet. 2003;12:2753&#x2013;2764. doi: 10.1093/hmg/ddg312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddg312</ArticleId><ArticleId IdType="pubmed">12966034</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn LI, et al. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science. 1998;281:1851&#x2013;1856. doi: 10.1126/science.281.5384.1851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.281.5384.1851</ArticleId><ArticleId IdType="pubmed">9743498</ArticleId></ArticleIdList></Reference><Reference><Citation>Redler RL, Dokholyan NV. The complex molecular biology of amyotrophic lateral sclerosis (ALS) Prog. Mol. Biol. Transl. Sci. 2012;107:215&#x2013;262. doi: 10.1016/B978-0-12-385883-2.00002-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-385883-2.00002-3</ArticleId><ArticleId IdType="pmc">PMC3605887</ArticleId><ArticleId IdType="pubmed">22482452</ArticleId></ArticleIdList></Reference><Reference><Citation>Proctor EA, et al. Nonnative SOD1 trimer is toxic to motor neurons in a model of amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA. 2016;113:614&#x2013;619. doi: 10.1073/pnas.1516725113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1516725113</ArticleId><ArticleId IdType="pmc">PMC4725519</ArticleId><ArticleId IdType="pubmed">26719414</ArticleId></ArticleIdList></Reference><Reference><Citation>Foster AD, Rea SL. The role of sequestosome 1/p62 protein in amyotrophic lateral sclerosis and frontotemporal dementia pathogenesis. Neural Regen. Res. 2020;15:2186&#x2013;2194. doi: 10.4103/1673-5374.284977.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.284977</ArticleId><ArticleId IdType="pmc">PMC7749485</ArticleId><ArticleId IdType="pubmed">32594029</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippai M, L&#x151;w P. The role of the selective adaptor p62 and ubiquitin-like proteins in autophagy. Biomed. Res. Int. 2014;2014:832704. doi: 10.1155/2014/832704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/832704</ArticleId><ArticleId IdType="pmc">PMC4075091</ArticleId><ArticleId IdType="pubmed">25013806</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshii SR, Noboru M. Monitoring and measuring autophagy. Int. J. Mol. Sci. 2017;18:1865. doi: 10.3390/ijms18091865.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18091865</ArticleId><ArticleId IdType="pmc">PMC5618514</ArticleId><ArticleId IdType="pubmed">28846632</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuchitsu Y, Fukuda M. Revisiting Rab7 functions in mammalian autophagy: Rab7 knockout studies. Cells. 2018;7:215&#x2013;226. doi: 10.3390/cells7110215.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells7110215</ArticleId><ArticleId IdType="pmc">PMC6262614</ArticleId><ArticleId IdType="pubmed">30463228</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xe4;ger S, et al. Role for Rab7 in maturation of late autophagic vacuoles. J. Cell. Sci. 2004;117:4837&#x2013;4848. doi: 10.1242/jcs.01370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.01370</ArticleId><ArticleId IdType="pubmed">15340014</ArticleId></ArticleIdList></Reference><Reference><Citation>Kou X, et al. Vorinostat and simvastatin have synergistic effects on triple-negative breast cancer cells via abrogating rab7 prenylation. Eur. J. Pharmacol. 2017;15:813&#x2013;824.</Citation><ArticleIdList><ArticleId IdType="pubmed">28826913</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranieri R, et al. N6-isopentenyladenosine dual targeting of AMPK and Rab7 prenylation inhibits melanoma growth through the impairment of autophagic flux. Cell Death Differ. 2018;25:353&#x2013;367. doi: 10.1038/cdd.2017.165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2017.165</ArticleId><ArticleId IdType="pmc">PMC5762849</ArticleId><ArticleId IdType="pubmed">29027991</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong L, et al. A Pan-GTPase inhibitor as a molecular probe. PloS ONE. 2015;10:e0134317. doi: 10.1371/journal.pone.0134317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0134317</ArticleId><ArticleId IdType="pmc">PMC4527730</ArticleId><ArticleId IdType="pubmed">26247207</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin Y, et al. CID1067700, a late endosome GTPase Rab7 receptor antagonist, attenuates brain atrophy, improves neurologic deficits and inhibits reactive astrogliosis in rat ischemic stroke. Acta Pharmacol. Sin. 2019;40:724&#x2013;736. doi: 10.1038/s41401-018-0166-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41401-018-0166-8</ArticleId><ArticleId IdType="pmc">PMC6786391</ArticleId><ArticleId IdType="pubmed">30315251</ArticleId></ArticleIdList></Reference><Reference><Citation>Fracassi A, Marangoni M, Rosso P, Pallottini V, Segatto M. Statins and the brain: more than lipid lowering agents? Curr. Neuropharmacol. 2019;17:59&#x2013;83. doi: 10.2174/1570159X15666170703101816.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570159X15666170703101816</ArticleId><ArticleId IdType="pmc">PMC6341496</ArticleId><ArticleId IdType="pubmed">28676012</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirtori CR. The pharmacology of statins. Pharmacol. Res. 2014;88:3&#x2013;11. doi: 10.1016/j.phrs.2014.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2014.03.002</ArticleId><ArticleId IdType="pubmed">24657242</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmadi M, et al. Pleiotropic effects of statins: a focus on cancer. Biochim Biophys. Acta Mol. Basis Dis. 2020;1866:165968. doi: 10.1016/j.bbadis.2020.165968.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2020.165968</ArticleId><ArticleId IdType="pubmed">32927022</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph AC, et al. Guidelines for the preclinical in vivo evaluation of pharmacological active drugs for ALS/MND: report on the 142nd ENMC international workshop. Amyotroph. Lateral Scler. 2007;8:217&#x2013;223. doi: 10.1080/17482960701292837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960701292837</ArticleId><ArticleId IdType="pubmed">17653919</ArticleId></ArticleIdList></Reference><Reference><Citation>Barr FA. Rab GTPases and membrane identity: causal or inconsequential? J. Cell Biol. 2013;202:191&#x2013;199. doi: 10.1083/jcb.201306010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201306010</ArticleId><ArticleId IdType="pmc">PMC3718981</ArticleId><ArticleId IdType="pubmed">23878272</ArticleId></ArticleIdList></Reference><Reference><Citation>Woschek M, Kneip N, Jurida K, Marzi I, Relja B. Simvastatin reduces cancerogenic potential of renal cancer cells via geranylgeranyl pyrophosphate and mevalonate pathway. Nutr. Cancer. 2016;68:420&#x2013;427. doi: 10.1080/01635581.2016.1152383.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01635581.2016.1152383</ArticleId><ArticleId IdType="pubmed">27042994</ArticleId></ArticleIdList></Reference><Reference><Citation>Oesterle A, Liao JK. The pleiotropic effects of statins-from coronary artery disease and stroke to atrial fibrillation and ventricular tachyarrhythmia. Curr. Vasc. Pharm. 2019;17:222&#x2013;232. doi: 10.2174/1570161116666180817155058.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570161116666180817155058</ArticleId><ArticleId IdType="pmc">PMC6378117</ArticleId><ArticleId IdType="pubmed">30124154</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Kant R, et al. Cholesterol metabolism is a druggable axis that independently regulates tau and amyloid-&#x3b2; in iPSC-derived Alzheimer&#x2019;s disease neurons. Cell Stem Cell. 2019;24:363&#x2013;375.e9. doi: 10.1016/j.stem.2018.12.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2018.12.013</ArticleId><ArticleId IdType="pmc">PMC6414424</ArticleId><ArticleId IdType="pubmed">30686764</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohm TG, et al. Cholesterol and tau protein-findings in alzheimer&#x2019;s and niemann pickc&#x2019;s disease. Pharmacopsychiatry. 2003;36:S120&#x2013;S126. doi: 10.1055/s-2003-43060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2003-43060</ArticleId><ArticleId IdType="pubmed">14574625</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>